Hangzhou Biotest Biotech Co Ltd (688767) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Hangzhou Biotest Biotech Co Ltd (688767) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.39 Million ≈ $4.15 Million USD) by net assets (CN¥2.34 Billion ≈ $342.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hangzhou Biotest Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Hangzhou Biotest Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688767 current and long-term liabilities for a breakdown of total debt and financial obligations.

Hangzhou Biotest Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hangzhou Biotest Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Canaccord Genuity Group Inc TO:CF	0.333x
CW Enerji SA IS:CWENE	-0.008x
Zhejiang Xinao Textiles Inc SHG:603889	0.064x
Hangzhou Jizhi Mechatronic Co Ltd SHE:300553	0.029x
Astra Agro Lestari Tbk JK:AALI	0.063x
DL Holdings CO. LTD. KO:000210	0.026x
Shenzhen Fuanna Bedding and Furnishing Co Ltd SHE:002327	0.032x
Shenzhen Sunxing Light Alloys SHG:603978	-0.074x

Annual Cash Flow Conversion Efficiency for Hangzhou Biotest Biotech Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Hangzhou Biotest Biotech Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 688767 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.41 Billion ≈ $353.00 Million	CN¥128.83 Million ≈ $18.85 Million	0.053x	-1.60%
2023-12-31	CN¥2.42 Billion ≈ $354.23 Million	CN¥131.38 Million ≈ $19.23 Million	0.054x	-80.22%
2022-12-31	CN¥2.56 Billion ≈ $374.94 Million	CN¥703.21 Million ≈ $102.90 Million	0.274x	-36.29%
2021-12-31	CN¥2.11 Billion ≈ $308.49 Million	CN¥908.12 Million ≈ $132.89 Million	0.431x	-57.22%
2020-12-31	CN¥443.02 Million ≈ $64.83 Million	CN¥446.07 Million ≈ $65.27 Million	1.007x	+394.07%
2019-12-31	CN¥125.95 Million ≈ $18.43 Million	CN¥25.67 Million ≈ $3.76 Million	0.204x	-5.51%
2018-12-31	CN¥98.15 Million ≈ $14.36 Million	CN¥21.17 Million ≈ $3.10 Million	0.216x	+142.81%
2017-12-31	CN¥79.63 Million ≈ $11.65 Million	CN¥7.07 Million ≈ $1.04 Million	0.089x	--

About Hangzhou Biotest Biotech Co Ltd

SHG:688767 China Biotechnology

Market Cap

$907.96 Million

CN¥6.20 Billion CNY

Market Cap Rank

#9650 Global

#2721 in China

Share Price

CN¥41.55

Change (1 day)

+2.09%

52-Week Range

CN¥30.56 - CN¥48.37

All Time High

CN¥125.45